(1->4)-beta-D-glucan multiple interactions ISO Igfbp7 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IGFBP7 mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression ISO Igfbp7 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of IGFBP7 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP7 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of IGFBP7 mRNA CTD PMID:17108234 17beta-estradiol increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Estradiol results in increased expression of IGFBP7 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP7 mRNA CTD PMID:17101203 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp7 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP7 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp7 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP7 mRNA CTD PMID:15034205 and PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Igfbp7 (Mus musculus) 6480464 AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of IGFBP7 mRNA] CTD PMID:15034205 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3-chloropropane-1,2-diol increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of IGFBP7 protein CTD PMID:34915118 4,4'-sulfonyldiphenol affects expression ISO Igfbp7 (Mus musculus) 6480464 bisphenol S affects the expression of IGFBP7 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO Igfbp7 (Mus musculus) 6480464 bisphenol S affects the methylation of IGFBP7 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bisphenol S results in decreased methylation of IGFBP7 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO Igfbp7 (Mus musculus) 6480464 Fenretinide results in increased expression of IGFBP7 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of IGFBP7 mRNA] CTD PMID:21095227 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of IGFBP7 mRNA and Decitabine results in increased expression of IGFBP7 protein CTD PMID:16367923 and PMID:18981723 5-aza-2'-deoxycytidine affects methylation EXP 6480464 Decitabine affects the methylation of IGFBP7 exon CTD PMID:17334979 6-propyl-2-thiouracil decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of IGFBP7 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of IGFBP7 mRNA CTD PMID:25825206 acetamide increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 acetamide results in increased expression of IGFBP7 mRNA CTD PMID:31881176 acrylamide decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of IGFBP7 mRNA CTD PMID:28959563 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of IGFBP7 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IGFBP7 mRNA CTD PMID:21632981 and PMID:21641981 aflatoxin B1 increases expression ISO Igfbp7 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of IGFBP7 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of IGFBP7 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of IGFBP7 mRNA CTD PMID:23724009 amitrole increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Amitrole results in increased expression of IGFBP7 mRNA CTD PMID:30047161 arachidonic acid decreases expression EXP 6480464 Arachidonic Acid results in decreased expression of IGFBP7 mRNA CTD PMID:16704987 arotinoid acid multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGFBP7 mRNA CTD PMID:32525701 arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGFBP7 mRNA CTD PMID:32525701 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of IGFBP7 mRNA] CTD PMID:29266867 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of IGFBP7 mRNA CTD PMID:15725085 and PMID:29266867 avobenzone increases expression EXP 6480464 avobenzone results in increased expression of IGFBP7 mRNA CTD PMID:31016361 benzo[a]pyrene increases expression ISO Igfbp7 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of IGFBP7 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of IGFBP7 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Igfbp7 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP7 mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions ISO Igfbp7 (Mus musculus) 6480464 AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of IGFBP7 mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of IGFBP7 mRNA CTD PMID:20106945 more ... beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of IGFBP7 mRNA CTD PMID:32858204 bexarotene multiple interactions ISO Igfbp7 (Rattus norvegicus) 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of IGFBP7 mRNA CTD PMID:17630414 bis(2-ethylhexyl) phthalate decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in decreased expression of IGFBP7 mRNA CTD PMID:19560483 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of IGFBP7 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of IGFBP7 protein CTD PMID:31163220 bisphenol A decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of IGFBP7 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Igfbp7 (Mus musculus) 6480464 bisphenol A results in decreased expression of IGFBP7 mRNA CTD PMID:35479511 and PMID:37105096 bisphenol A increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of IGFBP7 mRNA CTD PMID:32145629 bisphenol A increases expression ISO Igfbp7 (Mus musculus) 6480464 bisphenol A results in increased expression of IGFBP7 mRNA CTD PMID:30951980 bisphenol A affects expression ISO Igfbp7 (Rattus norvegicus) 6480464 bisphenol A affects the expression of IGFBP7 mRNA CTD PMID:30816183 bisphenol A increases methylation ISO Igfbp7 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of IGFBP7 gene CTD PMID:28505145 bisphenol F increases expression ISO Igfbp7 (Mus musculus) 6480464 bisphenol F results in increased expression of IGFBP7 mRNA CTD PMID:30951980 buspirone decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Buspirone results in decreased expression of IGFBP7 mRNA CTD PMID:24136188 butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IGFBP7 mRNA CTD PMID:29432896 Butylbenzyl phthalate decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 butylbenzyl phthalate results in decreased expression of IGFBP7 mRNA CTD PMID:19560483 cadmium atom multiple interactions ISO Igfbp7 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP7 mRNA CTD PMID:33259630 cadmium dichloride multiple interactions EXP 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA CTD PMID:12634122 cadmium dichloride multiple interactions ISO Igfbp7 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP7 mRNA CTD PMID:33259630 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of IGFBP7 mRNA CTD PMID:25979313 carnosic acid decreases expression ISO Igfbp7 (Mus musculus) 6480464 salvin results in decreased expression of IGFBP7 protein CTD PMID:35926579 CHIR 99021 multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloropicrin decreases expression EXP 6480464 chloropicrin results in decreased expression of IGFBP7 mRNA CTD PMID:26352163 and PMID:28476498 chlorpyrifos increases expression ISO Igfbp7 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of IGFBP7 mRNA CTD PMID:37019170 cisplatin affects expression ISO Igfbp7 (Mus musculus) 6480464 Cisplatin affects the expression of IGFBP7 mRNA CTD PMID:21151649 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of IGFBP7 mRNA CTD PMID:19320972 cobalt dichloride decreases secretion EXP 6480464 cobaltous chloride results in decreased secretion of IGFBP7 protein CTD PMID:22079246 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA and [Disulfiram binds to Copper] which results in increased expression of IGFBP7 protein CTD PMID:24690739 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA and [Disulfiram binds to Copper] which results in increased expression of IGFBP7 protein CTD PMID:24690739 cortisol multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of IGFBP7 protein CTD PMID:29553831 Cuprizon increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of IGFBP7 mRNA CTD PMID:27523638 curcumin increases expression EXP 6480464 Curcumin results in increased expression of IGFBP7 mRNA CTD PMID:21594647 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of IGFBP7 mRNA CTD PMID:25562108 and PMID:27989131 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of IGFBP7 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether affects expression EXP 6480464 decabromobiphenyl ether affects the expression of IGFBP7 mRNA CTD PMID:24834073 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of IGFBP7 mRNA] CTD PMID:29266867 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of IGFBP7 mRNA CTD PMID:15725085 and PMID:29266867 dibromoacetic acid decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 dibromoacetic acid results in decreased expression of IGFBP7 mRNA CTD PMID:21046364 dibutyl phthalate decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of IGFBP7 mRNA CTD PMID:19560483 dichromium trioxide multiple interactions EXP 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA CTD PMID:12634122 dipentyl phthalate decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 di-n-pentyl phthalate results in decreased expression of IGFBP7 mRNA CTD PMID:19560483 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of IGFBP7 mRNA CTD PMID:18175754 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA and [Disulfiram binds to Copper] which results in increased expression of IGFBP7 protein CTD PMID:24690739 disulfiram increases expression EXP 401960877 [Disulfiram cotreated with copper(+2)] increases expression of IGFBP7 mRNA in malignant pleural mesothelioma cells RGD dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance EXP 6480464 IGFBP7 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of IGFBP7 mRNA CTD PMID:29803840 endosulfan decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of IGFBP7 mRNA CTD PMID:29391264 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA CTD PMID:27188386 entinostat increases expression EXP 6480464 entinostat results in increased expression of IGFBP7 mRNA CTD PMID:26272509 ethanol multiple interactions EXP 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IGFBP7 mRNA CTD PMID:29432896 etoposide affects response to substance EXP 6480464 IGFBP7 protein affects the susceptibility to Etoposide CTD PMID:16217747 folic acid decreases expression ISO Igfbp7 (Mus musculus) 6480464 Folic Acid results in decreased expression of IGFBP7 mRNA CTD PMID:25629700 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of IGFBP7 mRNA CTD PMID:21867686 furan increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 furan results in increased expression of IGFBP7 mRNA CTD PMID:27387713 graphene oxide increases expression EXP 6480464 graphene oxide results in increased expression of IGFBP7 protein CTD PMID:33219560 and PMID:33219563 hexadecanoic acid increases expression EXP 401960873 Palmitic acid increases expression of IGFBP7 mRNA and protein in hepatoma cells RGD hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of IGFBP7 mRNA CTD PMID:32949572 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of IGFBP7 protein CTD PMID:32959892 ketoconazole increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Ketoconazole results in increased expression of IGFBP7 mRNA CTD PMID:37077353 L-ascorbic acid multiple interactions EXP 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions EXP 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA CTD PMID:34480604 lead diacetate multiple interactions EXP 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA CTD PMID:12634122 mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of IGFBP7 mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA CTD PMID:27188386 methimazole increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Methimazole results in increased expression of IGFBP7 mRNA CTD PMID:30047161 methotrexate affects response to substance EXP 6480464 IGFBP7 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of IGFBP7 mRNA CTD PMID:28001369 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of IGFBP7 mRNA CTD PMID:34089799 mitoxantrone affects response to substance EXP 6480464 IGFBP7 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-nitrosodiethylamine increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of IGFBP7 mRNA CTD PMID:19638242 nefazodone decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of IGFBP7 mRNA CTD PMID:24136188 nimesulide decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of IGFBP7 mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO Igfbp7 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP7 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of IGFBP7 mRNA CTD PMID:25729387 ozone decreases expression ISO Igfbp7 (Mus musculus) 6480464 Ozone results in decreased expression of IGFBP7 mRNA CTD PMID:12763052 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of IGFBP7 mRNA CTD PMID:26272509 paracetamol affects expression ISO Igfbp7 (Mus musculus) 6480464 Acetaminophen affects the expression of IGFBP7 mRNA CTD PMID:17562736 paracetamol increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of IGFBP7 mRNA CTD PMID:33387578 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IGFBP7 mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of IGFBP7 mRNA CTD PMID:35182771 perfluorooctane-1-sulfonic acid multiple interactions ISO Igfbp7 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IGFBP7 mRNA CTD PMID:36331819 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of IGFBP7 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA CTD PMID:16979875 phosgene affects expression ISO Igfbp7 (Mus musculus) 6480464 Phosgene affects the expression of IGFBP7 mRNA CTD PMID:16300373 potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of IGFBP7 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP7 mRNA CTD PMID:30047161 quercetin increases expression ISO Igfbp7 (Mus musculus) 6480464 Quercetin results in increased expression of IGFBP7 mRNA CTD PMID:16455785 rotenone decreases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Rotenone results in decreased expression of IGFBP7 mRNA CTD PMID:28374803 Salinomycin decreases expression EXP 6480464 salinomycin results in decreased expression of IGFBP7 mRNA CTD PMID:19682730 SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:34480604 silver atom decreases expression ISO Igfbp7 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP7 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Igfbp7 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP7 mRNA CTD PMID:27131904 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGFBP7 mRNA CTD PMID:32525701 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA CTD PMID:12634122 Soman increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Soman results in increased expression of IGFBP7 mRNA CTD PMID:19281266 streptozocin increases expression ISO Igfbp7 (Mus musculus) 6480464 Streptozocin results in increased expression of IGFBP7 mRNA CTD PMID:29673160 sulfadimethoxine increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of IGFBP7 mRNA CTD PMID:30047161 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of IGFBP7 mRNA CTD PMID:31533062 tamoxifen increases expression ISO Igfbp7 (Mus musculus) 6480464 Tamoxifen results in increased expression of IGFBP7 mRNA CTD PMID:25123088 tamoxifen multiple interactions ISO Igfbp7 (Rattus norvegicus) 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of IGFBP7 mRNA CTD PMID:17630414 temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of IGFBP7 mRNA CTD PMID:31758290 testosterone decreases expression ISO Igfbp7 (Mus musculus) 6480464 Testosterone results in decreased expression of IGFBP7 mRNA CTD PMID:20403060 testosterone increases expression ISO Igfbp7 (Mus musculus) 6480464 Testosterone results in increased expression of IGFBP7 mRNA CTD PMID:20403060 tetrachloromethane increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of IGFBP7 mRNA CTD PMID:16239168 tetrachloromethane increases expression ISO Igfbp7 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of IGFBP7 mRNA CTD PMID:27339419 more ... tetrathiomolybdate(2-) increases expression EXP 6480464 tetrathiomolybdate results in increased expression of IGFBP7 mRNA CTD PMID:37290678 thioacetamide increases expression ISO Igfbp7 (Rattus norvegicus) 401976485 Thioacetamide increases expression of Igfbp7 protein in the liver RGD topotecan increases expression ISO Igfbp7 (Rattus norvegicus) 6480464 Topotecan results in increased expression of IGFBP7 mRNA CTD PMID:25729387 topotecan affects response to substance EXP 6480464 IGFBP7 protein affects the susceptibility to Topotecan CTD PMID:16217747 topotecan multiple interactions ISO Igfbp7 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP7 mRNA CTD PMID:25729387 triacsin C decreases expression EXP 6480464 triacsin C results in decreased expression of IGFBP7 mRNA CTD PMID:16704987 Tributyltin oxide increases expression ISO Igfbp7 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of IGFBP7 mRNA CTD PMID:18958704 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of IGFBP7 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA CTD PMID:27188386 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of IGFBP7 mRNA CTD PMID:30510588 urethane decreases expression EXP 6480464 Urethane results in decreased expression of IGFBP7 mRNA CTD PMID:28818685 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of IGFBP7 mRNA CTD PMID:29154799 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of IGFBP7 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO Igfbp7 (Mus musculus) 6480464 Valproic Acid affects the expression of IGFBP7 mRNA CTD PMID:17963808 vinclozolin affects expression ISO Igfbp7 (Rattus norvegicus) 6480464 vinclozolin affects the expression of IGFBP7 mRNA CTD PMID:19015723 XAV939 multiple interactions EXP 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA CTD PMID:34480604 zinc atom affects expression EXP 6480464 Zinc affects the expression of IGFBP7 mRNA CTD PMID:16979875 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA CTD PMID:16979875 zinc(0) affects expression EXP 6480464 Zinc affects the expression of IGFBP7 mRNA CTD PMID:16979875 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA CTD PMID:16979875
